<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31875015</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease.</ArticleTitle><Pagination><StartPage>19783</StartPage><MedlinePgn>19783</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19783</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-56381-3</ELocationID><Abstract><AbstractText>Chronic kidney disease is an epidemiologically identified risk factor for development of severe dengue in dengue-affected patients. However, available data on the immune pathogenesis in end stage renal disease (ESRD) patients affected by dengue is insufficient. We performed an in vitro study to evaluate the sequential immunological reactions and viral load in dengue virus type 2-infected mononuclear cells of patients with ESRD (n&#x2009;=&#x2009;34) and in healthy controls (n&#x2009;=&#x2009;30). The concentrations of interleukins (IL)-1 receptor antagonist (Ra), IL-2, IL-6, IL-8, IL-10, IL-12p40, granulocyte-macrophage colony-stimulating factor (GM-CSF), monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1b (MIP-1b), vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-&#x3b1; and viral load cycle threshold (Ct) were measured in the dengue virus type 2-infected mononuclear cells at 6&#x2009;h, 24&#x2009;h, 48&#x2009;h, and 72&#x2009;h post-infection. We found in the ESRD group significantly higher GM-CSF and IL-2 levels at 6&#x2009;h post-infection. However, IL-8, IL-10, IL-12p40, TNF-&#x3b1;, MCP-1, and MIP-1b levels were found significantly lower than in the control group. At 24&#x2009;h, 48&#x2009;h, and 72&#x2009;h post-infection, significantly lower levels of IL-1Ra, IL-6, IL-8, IL-10, IL-12p40, TNF-&#x3b1;, MCP-1, and MIP-1b were detected in ESRD group. Concentration of VEGF at 24&#x2009;h and 48&#x2009;h, and of GM-CSF at 48&#x2009;h and 72&#x2009;h were also found to be lower in ESRD group than in control group. Compared with controls, the viral load Ct values were significantly lower in ESRD group at 6&#x2009;h and 24&#x2009;h post-infection No significant difference in viral load Ct values between two groups was found at 48&#x2009;h and 72&#x2009;h post-infection. Our study discloses that the expression of immune mediators of dengue-infected mononuclear cells is impaired in ESRD patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ing-Kit</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan. leee@cgmh.org.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chang Gung University Medical College, Tao-Yuan, Taiwan. leee@cgmh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zih-Syuan</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Hwee-Yeong</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lung-Chih</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wen-Chi</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ching-Yen</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chien-Te</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Chang Gung University Medical College, Tao-Yuan, Taiwan. chientel@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan. chientel@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31875015</ArticleId><ArticleId IdType="pmc">PMC6930266</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-56381-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-56381-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, New ed. World Health Organization: Geneva, Switzerland (2009).</Citation></Reference><Reference><Citation>Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons CP, Farrar JJ, Nguyen VV, Will B. Dengue. N. Engl. J. Med. 2012;366:1423&#x2013;1432. doi: 10.1056/NEJMra1110265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1110265</ArticleId><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzelnick LC, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358:929&#x2013;932. doi: 10.1126/science.aan6836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan6836</ArticleId><ArticleId IdType="pmc">PMC5858873</ArticleId><ArticleId IdType="pubmed">29097492</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Mathew A, Rothman AL. Immune-mediated cytokine storm and its role in severe dengue. Semin. Immunopathol. 2017;39:563&#x2013;574. doi: 10.1007/s00281-017-0625-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0625-1</ArticleId><ArticleId IdType="pmc">PMC5496927</ArticleId><ArticleId IdType="pubmed">28401256</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo Joao, George Leyanna, Martinez Eric, Lazaro Adhara, Han Wai Wai, Coelho Giovanini E., Runge Ranzinger Silvia, Horstick Olaf. Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review. PLOS Neglected Tropical Diseases. 2016;10(1):e0004284. doi: 10.1371/journal.pntd.0004284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004284</ArticleId><ArticleId IdType="pmc">PMC4699776</ArticleId><ArticleId IdType="pubmed">26727113</ArticleId></ArticleIdList></Reference><Reference><Citation>Her Z, et al. Severity of plasma leakage is associated with high levels of interferon &#x3b3;-inducible protein 10, hepatocyte growth factor, matrix metalloproteinase 2 (MMP-2), and MMP-9 during dengue virus infection. J. Infect. Dis. 2017;215:42&#x2013;51. doi: 10.1093/infdis/jiw494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw494</ArticleId><ArticleId IdType="pubmed">28077582</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SN, Halstead SB. Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J. Pediatr. 1966;68:448&#x2013;456. doi: 10.1016/S0022-3476(66)80249-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(66)80249-4</ArticleId><ArticleId IdType="pubmed">5903315</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am. J. Trop. Med. Hyg. 1969;18:954&#x2013;971. doi: 10.4269/ajtmh.1969.18.954.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1969.18.954</ArticleId><ArticleId IdType="pubmed">5355242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Liu JW, Yang KD. Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 2008;79:149&#x2013;153. doi: 10.4269/ajtmh.2008.79.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2008.79.149</ArticleId><ArticleId IdType="pubmed">18689614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo HJ, Lee IK, Liu JW. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: Emphasizing risk of severe dengue in the elderly. J. Microbiol. Immunol. Infect. 2018;51:740&#x2013;748. doi: 10.1016/j.jmii.2016.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2016.08.024</ArticleId><ArticleId IdType="pubmed">28734676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CC, et al. A Cohort Study of Adult Patients with Severe Dengue in Taiwanese Intensive Care Units: The Elderly and APTT Prolongation Matter for Prognosis. PLoS Negl. Trop. Dis. 2017;11:e0005270. doi: 10.1371/journal.pntd.0005270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005270</ArticleId><ArticleId IdType="pmc">PMC5245902</ArticleId><ArticleId IdType="pubmed">28060934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo MC, et al. Impact of renal failure on the outcome of dengue viral infection. Clin. J. Am. Soc. Nephrol. 2008;3:1350&#x2013;356. doi: 10.2215/CJN.00020108.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00020108</ArticleId><ArticleId IdType="pmc">PMC2518807</ArticleId><ArticleId IdType="pubmed">18667746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo MC, et al. Difficulty in diagnosis and treatment of dengue hemorrhagic fever in patients with chronic renal failure: report of three cases of mortality. Am. J. Trop. Med. Hyg. 2007;76:752&#x2013;756. doi: 10.4269/ajtmh.2007.76.752.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2007.76.752</ArticleId><ArticleId IdType="pubmed">17426183</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun Thomas ET, George J, Sruthi D, Vineetha NS, Gracious N. Clinical course of dengue fever and its impact on renal function in renal transplant recipients and patients with chronic kidney disease. Nephrology (Carlton) 2019;24:564&#x2013;568. doi: 10.1111/nep.13265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13265</ArticleId><ArticleId IdType="pubmed">29607577</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbiah A, et al. Dengue fever in renal allograft recipients: Clinical course and outcome. Transpl. Infect. Dis. 2018;20:e12875. doi: 10.1111/tid.12875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.12875</ArticleId><ArticleId IdType="pubmed">29512853</ArticleId></ArticleIdList></Reference><Reference><Citation>Thein TL, et al. Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study. PloS one. 2013;8:e81060. doi: 10.1371/journal.pone.0081060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081060</ArticleId><ArticleId IdType="pmc">PMC3838336</ArticleId><ArticleId IdType="pubmed">24278377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Liu JW, Yang KD. Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am. J. Trop. Med. Hyg. 2009;80:651&#x2013;655. doi: 10.4269/ajtmh.2009.80.651.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2009.80.651</ArticleId><ArticleId IdType="pubmed">19346394</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CC, et al. Acute respiratory failure in adult patients with dengue virus infection. Am. J. Trop. Med. Hyg. 2007;77:151&#x2013;158. doi: 10.4269/ajtmh.2007.77.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2007.77.151</ArticleId><ArticleId IdType="pubmed">17620647</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Lee IK, Chen YC, Tsai CY, Liu JW. Characteristics and predictors for gastrointestinal hemorrhage among adult patients with dengue virus infection: Emphasizing the impact of existing comorbid disease(s) PLoS One. 2018;13:e0192919. doi: 10.1371/journal.pone.0192919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192919</ArticleId><ArticleId IdType="pmc">PMC5819790</ArticleId><ArticleId IdType="pubmed">29462169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758&#x2013;1764. doi: 10.1111/j.1523-1755.2000.00337.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2000.00337.x</ArticleId><ArticleId IdType="pubmed">11012910</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin. Diagn. Lab. Immunol. 2000;7:867&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC95976</ArticleId><ArticleId IdType="pubmed">11063489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Yeh WT, Yang MY, Yang KD. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol. Med. Microbiol. 2001;30:1&#x2013;7. doi: 10.1111/j.1574-695X.2001.tb01542.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2001.tb01542.x</ArticleId><ArticleId IdType="pubmed">11172984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WJ. Dengue outbreaks and the geographic distribution of dengue vectors in Taiwan: A 20-year epidemiological analysis. Biomed. J. 2018;41:283&#x2013;289. doi: 10.1016/j.bj.2018.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2018.06.002</ArticleId><ArticleId IdType="pmc">PMC6306330</ArticleId><ArticleId IdType="pubmed">30580791</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Wang L, Cheng JT, Yang KD. Induction of IFN&#x3b1; or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement. BMC Infect. Dis. 2012;12:340. doi: 10.1186/1471-2334-12-340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-340</ArticleId><ArticleId IdType="pmc">PMC3575308</ArticleId><ArticleId IdType="pubmed">23216989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, et al. Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes&#x2019; mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication. Biomed. Res. Int. 2013;2013:965853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3773921</ArticleId><ArticleId IdType="pubmed">24078930</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver KG, Kettman JR, Fulton RJ. Multiplexed analysis of human cytokines by use of the FlowMetrix system. Clin. Chem. 1998;44:2057&#x2013;2060.</Citation><ArticleIdList><ArticleId IdType="pubmed">9733011</ArticleId></ArticleIdList></Reference><Reference><Citation>Memish ZA, et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J. Infect. Dis. 2014;210:1590&#x2013;1594. doi: 10.1093/infdis/jiu292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu292</ArticleId><ArticleId IdType="pmc">PMC7107391</ArticleId><ArticleId IdType="pubmed">24837403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, I. K., Hsieh, C. J., Lee, C. T. &amp; Liu, J. W. Diabetic patients suffering dengue are at risk for development of dengue shock syndrome/severe dengue: Emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity. J. Microbiol. Immunol. Infect. pii: S1684-1182(18)30006-9, 10.1016/j.jmii.2017.12.005. [Epub ahead of print] (2018 Jan 31).</Citation><ArticleIdList><ArticleId IdType="pubmed">30146413</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS) Immunol. Cell Biol. 2007;85:43&#x2013;45. doi: 10.1038/sj.icb.7100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.icb.7100008</ArticleId><ArticleId IdType="pubmed">17130899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CK, et al. Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis. Immunol. Invest. 2007;36:47&#x2013;57. doi: 10.1080/08820130600745505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820130600745505</ArticleId><ArticleId IdType="pubmed">17190649</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don&#x2019;t know. Cell Res. 2006;16:126&#x2013;133. doi: 10.1038/sj.cr.7310017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7310017</ArticleId><ArticleId IdType="pubmed">16474424</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro A. Raj Kumar, Mohanty Sriprasad, Prusty Birendra K., Singh Diwakar K., Gaikwad Sagar, Saswat Tanuja, Chattopadhyay Soma, Das Bidyut K., Tripathy Rina, Ravindran Balachandran. Cytokine Signature Associated with Disease Severity in Dengue. Viruses. 2019;11(1):34. doi: 10.3390/v11010034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010034</ArticleId><ArticleId IdType="pmc">PMC6357178</ArticleId><ArticleId IdType="pubmed">30626045</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 2012;12:180&#x2013;190. doi: 10.1038/nri3156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3156</ArticleId><ArticleId IdType="pubmed">22343569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 1991;88:1473&#x2013;1480. doi: 10.1172/JCI115457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI115457</ArticleId><ArticleId IdType="pmc">PMC295652</ArticleId><ArticleId IdType="pubmed">1939640</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangada MM, et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J. Infect. Dis. 2002;185:1697&#x2013;1703. doi: 10.1086/340822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/340822</ArticleId><ArticleId IdType="pubmed">12085313</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, et al. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J. Virol. 2007;81:1592&#x2013;1600. doi: 10.1128/JVI.01642-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01642-06</ArticleId><ArticleId IdType="pmc">PMC1797579</ArticleId><ArticleId IdType="pubmed">17151115</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J. Virol. 2011;85:1671&#x2013;1683. doi: 10.1128/JVI.00220-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00220-10</ArticleId><ArticleId IdType="pmc">PMC3028884</ArticleId><ArticleId IdType="pubmed">21123382</ArticleId></ArticleIdList></Reference><Reference><Citation>Girndt M, Sester U, Sester M, Kaul H, K&#xf6;hler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol. Dial. Transplant. 1999;14:2807&#x2013;2810. doi: 10.1093/ndt/14.12.2807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/14.12.2807</ArticleId><ArticleId IdType="pubmed">10570074</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WH, Kireta S, Leedham E, Russ GR, Coates PT. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 2007;72:1138&#x2013;1148. doi: 10.1038/sj.ki.5002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002425</ArticleId><ArticleId IdType="pubmed">17728708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisowska KA, et al. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J. Clin. Immunol. 2012;32:189&#x2013;200. doi: 10.1007/s10875-011-9603-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-011-9603-x</ArticleId><ArticleId IdType="pmc">PMC3276768</ArticleId><ArticleId IdType="pubmed">21993694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling KA, Eftekhari P, Girndt M, Kimmel PL, Raj DS. The immunoregulatory function of vitamin D: implications in chronic kidney disease. Nat. Rev. Nephrol. 2012;8:403&#x2013;412. doi: 10.1038/nrneph.2012.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2012.93</ArticleId><ArticleId IdType="pubmed">22614789</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CM, et al. The exploration of risk factors of concurrent bacteraemia in patients critically ill with severe dengue. J. Med. Microbiol. 2016;65:1505&#x2013;1511. doi: 10.1099/jmm.0.000388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.000388</ArticleId><ArticleId IdType="pmc">PMC5203669</ArticleId><ArticleId IdType="pubmed">27902388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CM, Chan KS, Chao HC, Lai CC. Diagnostic performance of procalcitonin for bacteremia in patients with severe dengue infection in the intensive care unit. J. Infect. 2016;73:93&#x2013;95. doi: 10.1016/j.jinf.2016.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2016.03.013</ArticleId><ArticleId IdType="pubmed">27033048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003;305:330&#x2013;338. doi: 10.1006/viro.2002.1704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2002.1704</ArticleId><ArticleId IdType="pubmed">12573578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, et al. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 2005;44:43&#x2013;50. doi: 10.1016/j.femsim.2004.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.femsim.2004.11.012</ArticleId><ArticleId IdType="pubmed">15780577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>